GO:0004222 metalloendopeptidase activity: Mechanism, Genes and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0004222 metalloendopeptidase activity describes the catalysis of internal peptide bond hydrolysis using a water molecule activated by one or two metal ions, typically zinc [1, 6].
• This activity is essential for diverse physiological processes including mitochondrial stress responses, thrombolysis, and neuropeptide processing [1, 3, 7].
• Key gene families include matrix metalloproteinases (MMPs), ADAMs, and mitochondrial proteases such as OMA1 [1, 5].
• Dysregulation of metalloendopeptidases is linked to cancer, cardiovascular disease, neurodegeneration, and sarcoidosis [3, 5, 8].
• Research tools such as CRISPR knockout, point mutation, and overexpression models are critical for dissecting gene function [1, 2].
• EDITGENE provides comprehensive CRISPR services to accelerate metalloendopeptidase research.
Description
Metalloendopeptidases are a large and diverse family of proteolytic enzymes that cleave internal peptide bonds in proteins using a metal ion, usually zinc, to activate a water molecule [1, 6]. This activity, classified as GO:0004222 metalloendopeptidase activity, is fundamental to numerous biological processes, from mitochondrial quality control to blood clot dissolution and neuropeptide maturation [1, 3, 7]. The defining feature of these enzymes is their catalytic mechanism, which relies on one or two metal ions held in place by conserved amino acid ligands, most commonly histidine, glutamate, and aspartate residues. Understanding this mechanism is crucial for researchers studying proteolysis in health and disease. The importance of metalloendopeptidases extends across all kingdoms of life. In humans, they include matrix metalloproteinases (MMPs) involved in tissue remodeling, ADAM family proteases that shed cell surface proteins, and mitochondrial proteases like OMA1 that mediate stress responses [1, 5]. Their dysregulation contributes to cancer progression, cardiovascular disorders, and neurodegenerative diseases [3, 5, 8]. As such, metalloendopeptidases are attractive targets for therapeutic intervention and are the subject of intense research. This article provides a comprehensive overview of GO:0004222, covering its definition, molecular mechanism, key genes, disease associations, and modern research methods, including CRISPR-based approaches for functional studies.
metalloendopeptidase activity At A Glance
| GO ID | GO:0004222 |
|---|---|
| GO term | metalloendopeptidase activity |
| Ontology | molecular_function |
| Synonym | metalloendoprotease activity, metalloendoproteinase activity |
| Major function | Hydrolysis of internal peptide bonds in proteins using a metal ion cofactor |
| Metal ion cofactor | Typically zinc (Zn2+), sometimes cobalt or manganese |
| Catalytic residues | Histidine, glutamate, aspartate (metal ligands); glutamate (general base) |
| Subcellular localization | Varies: cytosol, mitochondria, extracellular matrix, membrane |
| Representative genes | MMP1, MMP2, MMP9, ADAM10, ADAM17, OMA1, neurolysin, etc. |
What Is GO:0004222?
GO:0004222 metalloendopeptidase activity is defined as the catalysis of the hydrolysis of internal alpha-peptide bonds in a polypeptide chain by a mechanism in which water acts as a nucleophile, one or two metal ions hold the water molecule in place, and charged amino acid side chains are ligands for the metal ions. In simpler terms, these enzymes cut proteins from the inside using a metal-assisted water molecule. This activity is distinct from exopeptidases, which cleave terminal peptide bonds, and from other endopeptidases that use different catalytic mechanisms (e.g., serine or cysteine proteases). The metal ions, typically zinc, are coordinated by conserved residues such as histidines and glutamates, forming the active site [1, 6].
Why Is metalloendopeptidase activity Important in Cell Biology?
Metalloendopeptidase activity is essential for a wide array of physiological processes, including protein quality control, cell signaling, tissue remodeling, and immune responses [1, 3, 5]. Dysregulation of these enzymes is implicated in numerous human diseases, such as cancer, cardiovascular disorders, neurodegeneration, and inflammatory conditions [3, 5, 8]. Therefore, understanding their mechanism and regulation is critical for developing targeted therapies and diagnostic tools.
• Mitochondrial stress response: OMA1 mediates DELE1 cleavage to activate the integrated stress response.
• Thrombolysis: metalloendopeptidases like plasminogen activators are used clinically to dissolve blood clots [3, 4].
• Neurodegeneration: ADAM10 and BACE1 are involved in amyloid precursor protein processing; lactate modulates their activity.
• Neuropeptide processing: neurolysin is a metalloendopeptidase that cleaves neurotensin and other peptides.
• Cancer: matrix metalloproteinases (MMPs) promote tumor invasion and metastasis.
• Inflammation: ADAM17 (TACE) sheds TNF-alpha and other cytokines.
• Sarcoidosis: elevated serum metalloendopeptidase activity has been observed in patients.
• Urinary biomarkers: metalloendopeptidase activity in urine can indicate renal function.
• T cell memory: SENP1-Sirt3 signaling involves mitochondrial proteases.
• Therapeutic targets: inhibitors of MMPs and ADAMs are under development for various diseases [3, 4].
What Happens During metalloendopeptidase activity?
Substrate Binding and Active Site Architecture
In simple terms: The enzyme grabs the protein target and positions it for cutting.
Metalloendopeptidases possess a conserved active site with a metal ion, typically zinc, coordinated by three amino acid residues (e.g., two histidines and a glutamate) and a water molecule [1, 6]. Substrate binding occurs in a groove or cleft adjacent to the metal ion, where the polypeptide chain is positioned so that the scissile bond is near the catalytic water. Specificity is determined by interactions between substrate side chains and enzyme subsites, which can vary widely among family members, allowing for diverse substrate repertoires.
Catalytic Mechanism: Water Activation and Peptide Bond Cleavage
In simple terms: The metal ion helps water become a powerful cutter that breaks the peptide bond.
The metal ion polarizes the water molecule, lowering its pKa and facilitating nucleophilic attack on the carbonyl carbon of the scissile peptide bond. A conserved glutamate residue acts as a general base, abstracting a proton from the water. The resulting tetrahedral intermediate is stabilized by the metal ion and other active site residues. Collapse of the intermediate leads to peptide bond cleavage, releasing the two product fragments. The metal ion is regenerated for subsequent cycles.
Cofactors and Metal Ion Requirements
In simple terms: These enzymes need a metal helper, usually zinc, to work.
Most metalloendopeptidases require zinc for activity, but some can utilize cobalt or manganese. The metal ion is tightly bound and essential for catalysis; removal by chelating agents such as EDTA abolishes activity. In some enzymes, a second metal ion may play a structural role or modulate substrate specificity. The metal ligands are typically found in a consensus sequence such as HEXXH, a hallmark of the zincin superfamily.
Regulation of Metalloendopeptidase Activity
In simple terms: Cells control when and where these enzymes are active.
Metalloendopeptidase activity is regulated at multiple levels: gene expression, zymogen activation (e.g., MMPs are secreted as proenzymes requiring proteolytic removal of a prodomain), compartmentalization, and inhibition by endogenous inhibitors such as TIMPs (tissue inhibitors of metalloproteinases) [3, 5]. Post-translational modifications, such as phosphorylation, can also modulate activity. In mitochondria, OMA1 activity is controlled by membrane potential and stress signals. Additionally, metabolic cues like glucose limitation can influence mitochondrial proteases via AMPK-SENP1-Sirt3 signaling.
Key Genes Involved in GO:0004222 metalloendopeptidase activity
The following table lists representative genes encoding metalloendopeptidases, their major roles, and their relevance to research.
| Gene | Major Role | Research Relevance |
|---|---|---|
| MMP1 | Collagenase; degrades extracellular matrix | Cancer invasion, arthritis |
| MMP2 | Gelatinase A; ECM remodeling | Tumor metastasis, cardiovascular disease |
| MMP9 | Gelatinase B; inflammation, ECM degradation | Cancer, neuroinflammation |
| ADAM10 | Sheddase; cleaves Notch, APP | Alzheimer's disease, cancer |
| ADAM17 | TACE; sheds TNF-alpha, EGFR ligands | Inflammation, cancer |
| OMA1 | Mitochondrial protease; stress response | Mitochondrial quality control, neurodegeneration |
| Neurolysin | Neuropeptide processing | Hypertension, neuropeptide signaling |
| BACE1 | Beta-secretase; APP cleavage | Alzheimer's disease |
| ECE1 | Endothelin-converting enzyme | Cardiovascular disease |
| ACE | Angiotensin-converting enzyme | Hypertension, COVID-19 |
| Neprilysin | Degrades amyloid-beta, enkephalins | Alzheimer's disease, pain |
| Pitrilysin | Mitochondrial protease | Mitochondrial function |
| Insulysin | Insulin-degrading enzyme | Diabetes, Alzheimer's disease |
| MMP14 | MT1-MMP; pericellular proteolysis | Cancer invasion, angiogenesis |
| ADAMTS1 | Versicanase; ECM turnover | Cancer, development |
| TACE/ADAM17 | Cytokine shedding | Rheumatoid arthritis, cancer |
| Meprin A | Brush border protease | Kidney disease, inflammation |
| Thermolysin | Bacterial protease (model enzyme) | Enzyme mechanism studies |
How Is metalloendopeptidase activity Regulated?
Metalloendopeptidase activity is regulated at multiple levels. Gene expression is controlled by transcription factors and epigenetic mechanisms. Many are synthesized as inactive zymogens that require proteolytic activation. Endogenous inhibitors, such as TIMPs for MMPs, provide tight spatial and temporal control. Compartmentalization ensures activity occurs at specific sites, e.g., membrane-bound ADAMs vs. secreted MMPs. Post-translational modifications, including phosphorylation and glycosylation, can modulate activity. In mitochondria, OMA1 is activated by membrane depolarization and stress, leading to DELE1 cleavage and HRI-dependent integrated stress response. Metabolic signals, such as glucose limitation, can activate AMPK-SENP1-Sirt3 signaling, influencing mitochondrial proteases and T cell memory development.
metalloendopeptidase activity and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| MMP9 | Cancer metastasis, neuroinflammation | Knockout mice, xenograft models |
| ADAM10 | Alzheimer's disease, cancer | Conditional knockout, knock-in of familial mutations |
| OMA1 | Mitochondrial stress, neurodegeneration | KO cell lines, point mutation (catalytic dead) |
| BACE1 | Alzheimer's disease | Knockout mice, overexpression models |
| ACE | Hypertension, COVID-19 | Knock-in humanized mice, point mutation |
Cancer
Metalloendopeptidases, particularly matrix metalloproteinases (MMPs) and ADAMs, are frequently overexpressed in tumors and promote invasion, metastasis, and angiogenesis by degrading extracellular matrix and shedding growth factors. For example, MMP2 and MMP9 are associated with poor prognosis in various cancers. ADAM17 sheds TNF-alpha and EGFR ligands, fueling inflammation and proliferation. Targeting these enzymes is a therapeutic strategy, though clinical trials of MMP inhibitors have shown limited success due to specificity issues.
Neurodegenerative Diseases
In Alzheimer's disease, BACE1 (beta-secretase) and ADAM10 compete for APP processing; ADAM10 is neuroprotective, while BACE1 generates amyloid-beta. Lactate has been shown to increase ADAM10 activity and reduce BACE1 activity in mouse brain, suggesting metabolic modulation. Neurolysin, a metalloendopeptidase, degrades neurotensin and is implicated in Parkinson's disease and stroke. OMA1-mediated mitochondrial stress response is linked to neurodegeneration.
Cardiovascular and Inflammatory Diseases
Thrombolytic agents such as tissue plasminogen activator (tPA) are metalloendopeptidases used to dissolve blood clots in myocardial infarction and stroke [3, 4]. ACE (angiotensin-converting enzyme) regulates blood pressure and is a target for hypertension drugs. ADAM17 (TACE) is a key sheddase for TNF-alpha and is implicated in rheumatoid arthritis and inflammatory bowel disease. Elevated serum metalloendopeptidase activity has been observed in sarcoidosis patients.
Metabolic and Renal Disorders
Insulysin (insulin-degrading enzyme) plays a role in insulin signaling and is linked to type 2 diabetes and Alzheimer's disease. Meprin A, a metalloendopeptidase in kidney brush border, is involved in acute kidney injury and inflammation. Urinary metalloendopeptidase activity can serve as a biomarker for renal dysfunction. Glucose limitation activates AMPK-SENP1-Sirt3 signaling, which affects mitochondrial proteases and T cell memory, linking metabolism to immune function.
From metalloendopeptidase activity-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| What is the role of OMA1 in mitochondrial stress? | OMA1 knockout HeLa cells, point mutation (catalytic dead) |
| How does ADAM10 cleavage of APP affect amyloid-beta? | ADAM10 knock-in mice with mutated cleavage site |
| Does MMP9 promote tumor invasion? | MMP9 knockout in cancer cell lines, overexpression |
| What is the effect of neurolysin on neurotensin signaling? | Neurolysin knockout mice, tagged knock-in for localization |
| How does lactate regulate ADAM10 activity? | ADAM10 overexpression in neuronal cells, point mutation |
| Can ACE2 variants affect SARS-CoV-2 entry? | ACE2 knock-in mice, point mutation |
How to Study the metalloendopeptidase activity Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Fluorogenic peptide assay | Enzymatic activity | Inhibitor screening, kinetics |
| Zymography | Active enzyme levels | MMP detection in conditioned media |
| TAILS proteomics | Substrate cleavage sites | Degradome mapping |
| CRISPR knockout screen | Gene essentiality, synthetic lethality | Identify regulators of protease activity |
| CRISPRa/CRISPRi | Gain/loss of function | Study gene dosage effects |
| Live-cell imaging | Localization, dynamics | Mitochondrial stress response |
| Immunohistochemistry | Protein expression in tissues | Cancer biomarker studies |
Enzymatic Activity Assays
Metalloendopeptidase activity can be measured using fluorogenic or colorimetric peptide substrates. For example, MMP activity is often assayed with a peptide containing a fluorescent group that is released upon cleavage. These assays are used to screen inhibitors and determine kinetic parameters. Zymography, which involves electrophoresis of samples in gels containing a substrate (e.g., gelatin), allows detection of active enzymes by clear bands after staining.
Proteomics and Substrate Identification
Mass spectrometry-based proteomics, such as terminal amine isotopic labeling of substrates (TAILS), can identify natural substrates of metalloendopeptidases by enriching for neo-N-termini generated by cleavage. This approach has been used to map the degradome of MMPs and ADAMs. Quantitative proteomics can also assess changes in protein abundance upon enzyme knockout or inhibition.
Genetic and CRISPR Screens
CRISPR knockout screens can identify genes that modulate metalloendopeptidase activity or sensitivity to inhibitors. For example, a genome-wide screen could reveal synthetic lethal interactions with MMP inhibitors. CRISPR activation (CRISPRa) and interference (CRISPRi) enable gain- and loss-of-function studies. These methods are powerful for uncovering regulatory networks [1, 2].
Imaging and Localization
Fluorescent tagging of metalloendopeptidases (e.g., GFP knock-in) allows real-time visualization of localization and trafficking. For instance, OMA1-GFP can be used to monitor mitochondrial dynamics under stress. FRET-based sensors can detect protease activity in live cells. Immunohistochemistry is used to assess expression in tissues.
How CRISPR Can Be Used to Study GO:0004222 metalloendopeptidase activity
Knockout
CRISPR knockout (KO) is used to completely ablate metalloendopeptidase genes to study their loss-of-function phenotypes. For example, OMA1 KO cells are used to dissect the mitochondrial stress response. KO models can reveal whether a gene is essential, and can be combined with stress conditions to uncover synthetic phenotypes. EDITGENE provides custom KO cell lines and mice.
Point Mutation
Point mutations can be introduced to specifically inactivate catalytic residues (e.g., glutamate to alanine in the HEXXH motif) or to mimic disease-associated variants. This allows separation of catalytic activity from other functions. For instance, a catalytically dead OMA1 mutant can be used to test if its role in stress signaling depends on proteolysis. EDITGENE offers precise point mutation services.
Knock-in
Knock-in (KI) models include tagging endogenous genes with fluorescent proteins or epitope tags for localization and interaction studies. KI of disease mutations (e.g., familial Alzheimer's mutations in ADAM10) can recapitulate human pathology. KI of reporter genes (e.g., luciferase) enables in vivo imaging. EDITGENE provides knock-in cell lines and mouse models.
Overexpression
Overexpression of metalloendopeptidases is used to study gain-of-function effects, such as increased cleavage of substrates or enhanced invasion in cancer models. For example, ADAM10 overexpression in neurons increases APP cleavage. Overexpression can be achieved via lentiviral transduction or transgenic models. EDITGENE offers custom overexpression services.
How EDITGENE Supports metalloendopeptidase activity Research
Researchers studying metalloendopeptidase activity-related genes often need to determine whether a candidate gene is causally involved in a specific biological process or disease. This requires precise genetic manipulation, which can be achieved through CRISPR-based technologies. EDITGENE specializes in providing such services to accelerate discovery.
Contact EDITGENE today to design your custom CRISPR model for metalloendopeptidase activity research.
Frequently Asked Questions About metalloendopeptidase activity
What is metalloendopeptidase activity?
Metalloendopeptidase activity (GO:0004222) is the catalysis of internal peptide bond hydrolysis in proteins using a metal ion, typically zinc, to activate a water molecule [1, 6].
What genes are involved in metalloendopeptidase activity?
Key genes include MMPs (e.g., MMP1, MMP2, MMP9), ADAMs (ADAM10, ADAM17), mitochondrial proteases (OMA1), neurolysin, BACE1, ACE, and many others [1, 3, 5, 7].
What diseases are associated with metalloendopeptidases?
They are linked to cancer, Alzheimer's disease, cardiovascular disorders, inflammation, and sarcoidosis [3, 5, 8].
How is metalloendopeptidase activity regulated?
Regulation occurs at multiple levels: gene expression, zymogen activation, endogenous inhibitors (e.g., TIMPs), compartmentalization, and post-translational modifications [3, 5].
What is the catalytic mechanism of metalloendopeptidases?
A metal ion (e.g., Zn2+) polarizes a water molecule, which attacks the peptide bond; a conserved glutamate acts as a general base [1, 6].
What are the synonyms for metalloendopeptidase activity?
Metalloendoprotease activity and metalloendoproteinase activity are synonyms for GO:0004222.
How can I study metalloendopeptidase activity in the lab?
Common methods include fluorogenic peptide assays, zymography, proteomics (TAILS), and CRISPR-based genetic screens [5, 6].
What CRISPR models are available for metalloendopeptidase research?
Knockout, point mutation, knock-in, and overexpression models can be generated for any gene; EDITGENE provides these services.
Which metalloendopeptidase is involved in mitochondrial stress?
OMA1 is a mitochondrial metalloendopeptidase that mediates DELE1 cleavage and activates the integrated stress response.
How does lactate affect metalloendopeptidase activity?
Lactate increases ADAM10 activity and reduces BACE1 activity in mouse brain, influencing APP processing.
Conclusion
Metalloendopeptidase activity (GO:0004222) is a fundamental enzymatic function with broad biological and clinical significance. From mitochondrial stress responses to neuropeptide processing and thrombolysis, these enzymes are central to health and disease. Understanding their mechanisms, regulation, and roles in pathology requires sophisticated experimental models. CRISPR-based approaches, including knockout, point mutation, knock-in, and overexpression, are indispensable tools for dissecting gene function. EDITGENE offers a comprehensive suite of services to support researchers in this endeavor, from custom cell line generation to high-throughput screening and bioinformatics analysis.
References
- 1. Guo X et al.. 2020. Mitochondrial stress is relayed to the cytosol by an OMA1-DELE1-HRI pathway.. Nature 579(7799):427-432 PMID: 32132707
- 2. He J et al.. 2021. Glucose limitation activates AMPK coupled SENP1-Sirt3 signalling in mitochondria for T cell memory development.. Nat Commun 12(1):4371 PMID: 34272364
- 3. Collen D et al.. 2005. Thrombolytic agents.. Thromb Haemost 93(4):627-30 PMID: 15841305
- 4. Klegerman ME. 2017. Translational initiatives in thrombolytic therapy.. Front Med 11(1):1-19 PMID: 28116631
- 5. Moberg I et al.. 2024. Lactate increases ADAM10 activity and reduces BACE1 activity in mouse brain.. J Physiol 602(20):5217-5228 PMID: 39298105
- 6. Beynon RJ et al.. 1991. Metalloendopeptidase activity in urine of rodents.. Biomed Biochim Acta 50(4-6):795-7 PMID: 1801757
- 7. Checler F et al.. 2018. Neurolysin: From Initial Detection to Latest Advances.. Neurochem Res 43(11):2017-2024 PMID: 30159819
- 8. Almenoff J et al.. 1984. Identification of a thermolysin-like metalloendopeptidase in serum: activity in normal subjects and in patients with sarcoidosis.. J Lab Clin Med 103(3):420-31 PMID: 6366093
